tradingkey.logo

Hologic Inc

HOLX
查看詳細走勢圖
75.190USD
+0.190+0.25%
收盤 12/15, 16:00美東報價延遲15分鐘
16.73B總市值
30.06本益比TTM

Hologic Inc

75.190
+0.190+0.25%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.25%

5天

+0.45%

1月

+1.40%

6月

+16.12%

今年開始到現在

+4.30%

1年

+2.09%

查看詳細走勢圖

TradingKey Hologic Inc股票評分

單位: USD 更新時間: 2025-12-12

操作建議

Hologic Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名51/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價75.36。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Hologic Inc評分

相關信息

行業排名
51 / 208
全市場排名
134 / 4592
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 19 分析師
持有
評級
75.357
目標均價
+0.68%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Hologic Inc亮點

亮點風險
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入4.10B美元
估值合理
公司最新PE估值29.98,處於3年歷史合理位
機構減倉
最新機構持股223.55M股,環比減少6.02%
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉5.70K股

Hologic Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Hologic Inc簡介

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
公司代碼HOLX
公司Hologic Inc
CEOMacmillan (Stephen P)
網址https://www.hologic.com/

常見問題

Hologic Inc(HOLX)的當前股價是多少?

Hologic Inc(HOLX)的當前股價是 75.190。

Hologic Inc 的股票代碼是什麼?

Hologic Inc的股票代碼是HOLX。

Hologic Inc股票的52週最高點是多少?

Hologic Inc股票的52週最高點是75.300。

Hologic Inc股票的52週最低點是多少?

Hologic Inc股票的52週最低點是51.900。

Hologic Inc的市值是多少?

Hologic Inc的市值是16.73B。

Hologic Inc的淨利潤是多少?

Hologic Inc的淨利潤為565.70M。

現在Hologic Inc(HOLX)的股票是買入、持有還是賣出?

根據分析師評級,Hologic Inc(HOLX)的總體評級為持有,目標價格為75.357。

Hologic Inc(HOLX)股票的每股收益(EPS TTM)是多少

Hologic Inc(HOLX)股票的每股收益(EPS TTM)是2.501。
KeyAI